Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-09-12
2006-09-12
Qian, Celine (Department: 1636)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S320100, C435S325000
Reexamination Certificate
active
07105496
ABSTRACT:
The present invention provides a method of inhibiting angiogenesis within a tissue by providing exogenous PEDF to cells associated with the tissue. The presence of exogenous PEDF inhibits angiogenesis within the tissue, in part by interfering with the ability of vascular endothelia to expand within the tissue. The invention also provides a method for determining the severity of a tumor be assaying for the presence of PEDF within the tumor. To facilitate the inventive methods, the present invention provides pharmaceutical compositions including sources of PEDF.
REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen
patent: 4980286 (1990-12-01), Morgan et al.
patent: 4996159 (1991-02-01), Glaser
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5424398 (1995-06-01), Middeldorp et al.
patent: 6288024 (2001-09-01), Bouck et al.
patent: 6670333 (2003-12-01), Bouck et al.
patent: WO 93/24529 (1993-12-01), None
patent: WO 95/33480 (1995-12-01), None
Adamis, et al., 1994, Am. J. Ophthalmol. 118:445.
Adamis, et al., 1996, Arch. Ophthalmol. 114:66.
Aiello, et al., 1994, N. Engl. J. Med.331:1480.
Stellmach, V., et al., 2001, PNAS, vol. 98 No. 5 2593-2597.
Aiello, et al., 1995, Proc. Natl. Acad. Sci. U.S.A. 92:10457.
Altschul, et al., 1997, Nucleic Acids Res. 25:3389-3402.
Bain, et al., 1994, Gene Therapy 1:S68.
Barany, et al, 1987, Int. J. Peptide Protein Res. 30:705-739.
Becerra, et al., 1993, J. Biol. Chem. 268:23148-23156.
Becerra, et al., 1995, J. of BIol. Chemistry 270:25992-25999.
Becerra, Chemistry and Biology of Serpins, Church, et al., Eds. (Plenum, New York, 1997), pp. 223-237.
Berns and Giraud, 1995, Ann. N.Y. Acad. Sci. 772:95-104.
Bouck, et al., 1996, Adv. Cancer 69:135-174.
Connolly, et al., 1988, Microvas. Res. 36:275-290.
DiPaolo, et al., 1995, Exp. Cell Res. 220:178-185.
Federoff, et al., 1992, Proc. Natl. Acad. Sci. USA 89:1636-1640.
Fink, et al., 1996, Ann. Rev. Neurosci. 19:265-287.
Folkman and Klagsbrun, 1987, Science 235:442-447.
Folkman and Shing, 1992, J. Biol. Chem. 267(16):10931-10934.
Folkman, et al., 1995, Molecular Basis of Cancer 206-232.
Folkman, 1986, J. Cancer Res. 46:467-473.
Folkman, 1989, J. Natl. Cancer Inst. 82:4-6.
Gasparini, 1996, Eur. J. Cancer 32A(14):2379-2385.
Goldberg, et al., 1988, Science 242:1412-1415.
Gulledge and Dewhirst, 1996, Anticancer Res. 16:741-749.
Hanahan and Folkman, 1996, Cell 86:353-364.
Hayasaka, et al., 1998, Life Sci. 63:1089-1096.
Kaminska and Niederkorn, 1993, Investig. Opthalmol. Vis. Sci. 34:222-230.
O'Reilly, et al., 1994, Cell 79:315-328.
O'Reilly, et al., 1997, Cell 88:277-285.
Ogata, et al., 1997, Curr. Eye Res. 16:9-18.
Pierce, et al., 1996, Arch. Ophthalmol. 114:1219-1228.
Pignolo, et al., 1993, J. Biol. Chem. 268:8949-8957.
Polverini, et al., 1991, Methods in Enzymology 198:440-450.
Polverini, et al., 1991, Methods in Enzymology 194:440.
Provis, et al., 1997, Exp. Eye Res. 65:555-568.
Smith, et al., 1994, Invest. Ophthalmol. Vis. Sci. 35:101-111.
Steele, et al., 1993, Proc. Natl. Acad. Sci. USA 90(4):1526-1530.
Sugita, et al., 1997, J. Neurosci. Res. 49:710-718.
Tanawaki, et al., 1995, J. Neurochem. 64:2509-2517.
Teicher, et al., 1994, Int. J. Cancer 57:920-925.
Tombran-Tink, et al., 1991, Exp. Eye Res. 53:411-414.
Tombran-Tink, et al., 1995, J. Neurosci., 15:4992-5003.
Vinores, et al, 1998, J. Neuroimmunol. 89:43-50.
Weidner 1991, New Eng. J. Med. 324(1):1-8.
Wu and Beccera, 1996, Investig. Ophthalmol. Vis. Sci. 37:1984-1993.
Xu, et al., 1991, Cancer Res. 51:4481-4485.
Bouck Noël P.
Crawford Susan E.
Dawson David W.
Gillis Paul R.
Stellmach Veronica M.
Morgan & Lewis & Bockius, LLP
Northwestern University
Qian Celine
LandOfFree
Methods and compositions for inhibiting angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for inhibiting angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inhibiting angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3572138